Cargando…

1210. Recommendations for Screening and Diagnosis of Chagas Disease in the United States

BACKGROUND: Over 300,000 people in the United States are infected with Trypanosoma cruzi, the protozoan parasite that causes Chagas disease (CD). Only about 1% of estimated U.S. cases have been identified, usually through blood donor screening, and most people are unaware they have the infection. Sc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forsyth, Colin, Manne-Goehler, Jen, Bern, Caryn, Whitman, Jeffrey, Edwards, Morven S, Hochberg, Natasha, Marcus, Rachel, Beatty, Norman, Castro, Yagahira, Coyle, Christina, Granados, Paula Stigler, Hamer, David H, Maguire, James, Gilman, Robert, Meymandi, Sheba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644607/ http://dx.doi.org/10.1093/ofid/ofab466.1402

Ejemplares similares

Recommendations for Screening and Diagnosis of Chagas Disease in the United States
por: Forsyth, Colin J, et al.
Publicado: (2021)

Neglected Testing for Neglected Tropical Diseases at the CDC
por: Beatty, Norman L., et al.
Publicado: (2022)

Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole
por: Yoshioka, Kota, et al.
Publicado: (2020)

Chagas Disease and Domestic Medical Screening Guidance for Newly Arrived Individuals Under a Humanitarian-Based Immigration Status: A Call for Action
por: Agudelo Higuita, Nelson Iván, et al.
Publicado: (2022)

1665. The Cascade of Care for the Strong Hearts Chagas Disease Screening and Treatment Program in East Boston, Massachusetts
por: Manne-Goehler, Jen, et al.
Publicado: (2019)

The resilience of Triatoma dimidiata: An analysis of reinfestation in the Nicaraguan Chagas disease vector control program (2010–2016)
por: Yoshioka, Kota, et al.
Publicado: (2018)

Estimating the Burden of Chagas Disease in the United States
por: Manne-Goehler, Jennifer, et al.
Publicado: (2016)

Primary Care-Based Screening for Trypanosoma cruzi in High-Risk Populations: Results of the Strong Hearts Pilot in East Boston, Massachusetts
por: Manne-Goehler, Jennifer, et al.
Publicado: (2017)

773. Screening for Chagas disease in East Boston, Massachusetts from 2017 – 2020 reveals 0.9% prevalence
por: Manne-Goehler, Jennifer, et al.
Publicado: (2020)

Use of a Novel Chagas Urine Nanoparticle Test (Chunap) for Diagnosis of Congenital Chagas Disease
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2014)

Neglected Parasitic Infections in the United States: Chagas Disease
por: Montgomery, Susan P., et al.
Publicado: (2014)

Treatment of Chagas Disease in the United States
por: Meymandi, Sheba, et al.
Publicado: (2018)

Effect of clinician information sessions on diagnostic testing for Chagas disease
por: Mahoney West, Helen, et al.
Publicado: (2022)

442. The Results of a Primary Care-based Screening Program for Trypanosoma cruzi in East Boston, Massachusetts
por: Manne-Goehler, Jennifer, et al.
Publicado: (2018)

Characteristics and efficacy of physical activity interventions to improve cardiometabolic and psychosocial outcomes in people living with HIV in sub-Saharan Africa: a protocol for a systematic review
por: Mabweazara, SZ, et al.
Publicado: (2023)

Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States
por: Forsyth, Colin, et al.
Publicado: (2019)

Prevalence of Chagas Disease Among Family Members of Previously Diagnosed Patients in Los Angeles, California
por: Hernandez, Salvador, et al.
Publicado: (2019)

875. Sex Differences in Academic Achievement and Faculty Rank in Academic Infectious Diseases
por: Manne-Goehler, Jennifer, et al.
Publicado: (2018)

1234. Increasing private sector investment in neglected tropical disease (NTD) research and development: a mixed methods study
por: Barofsky, Jeremy, et al.
Publicado: (2020)

Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment
por: Soverow, Jonathan, et al.
Publicado: (2019)

Cardiac inflammation and ventricular tachycardia in Chagas disease
por: Shapiro, Hilary, et al.
Publicado: (2017)

Recognition and screening for Chagas disease in the USA
por: Marcus, Rachel, et al.
Publicado: (2021)

Prevalence of Chagas Disease in the Latin American–born Population of Los Angeles
por: Meymandi, Sheba K., et al.
Publicado: (2017)

Evaluation of 2 Lateral Flow Rapid Tests in the Diagnosis of Chagas Disease in the Washington Metropolitan Area
por: Castro-Sesquen, Yagahira E, et al.
Publicado: (2021)

Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2016)

Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States
por: Irish, Amanda, et al.
Publicado: (2022)

Change in clinical knowledge of diabetes among primary healthcare providers in Indonesia: repeated cross-sectional survey of 5105 primary healthcare facilities
por: Stein, Dorit T, et al.
Publicado: (2020)

136. In Their Own words: a Qualitative Analysis of Factors Contributing to Gender Bias in Academic Advancement in Infectious Disease
por: Stead, Wendy, et al.
Publicado: (2020)

587. Equity in academic advancement: findings from an IDSA-sponsored survey of infectious disease physicians
por: Manne-Goehler, Jennifer, et al.
Publicado: (2020)

Infectious Complications of Intravenous Drug Use: A Single-Center Review of Hospitalized Patients in Massachusetts, 2012-2015
por: Rapoport, Alison B, et al.
Publicado: (2017)

1412. Spontaneous Intramedullary Abscess from Streptococcus anginosus Group: A Case Report and a Review of the Literature
por: Patterson, Monica M, et al.
Publicado: (2019)

Chagas Disease in People with HIV: A Narrative Review
por: Clark, Eva H., et al.
Publicado: (2021)

Postural changes in blood pressure among patients with diabetes attending a referral hospital in southwestern Uganda: a cross-sectional study
por: Migisha, Richard, et al.
Publicado: (2021)

1399. Clarithromycin–Rifampin-based Treatment for Non-tuberculous Mycobacterial Infections in Immunocompromised Patients Who Require Concomitant CYP-Metabolized Medications
por: Gonzalez-Bocco, Isabel H, et al.
Publicado: (2021)

Cell Death and Serum Markers of Collagen Metabolism during Cardiac Remodeling in Cavia porcellus Experimentally Infected with Trypanosoma cruzi
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2013)

Detection of Soluble Antigen and DNA of Trypanosoma cruzi in Urine Is Independent of Renal Injury in the Guinea Pig Model
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2013)

“It’s Like a Phantom Disease”: Patient Perspectives on Access to Treatment for Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2018)

High Inpatient Health Care Utilization and Charges Associated With Injection Drug Use–Related Infections: A Cohort Study, 2012–2015
por: Rapoport, Alison B, et al.
Publicado: (2021)

Prevalence of Chagas Disease in a U.S. Population of Latin American Immigrants with Conduction Abnormalities on Electrocardiogram
por: Traina, Mahmoud I., et al.
Publicado: (2017)

Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients
por: Castro-Sesquen, Yagahira E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7lu4eeq30mm17njm22hg9m7ep1